At a glance
- Originator Wyeth
- Class Anxiolytics
- Mechanism of Action 5-HT1A serotonin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Cognition disorders; Diabetes mellitus
Most Recent Events
- 19 Sep 1998 Discontinued-Preclinical for Anxiety disorders in USA (Unknown route)
- 19 Sep 1998 Discontinued-Preclinical for Cognition disorders in United Kingdom (Unknown route)
- 19 Sep 1998 Discontinued-Preclinical for Diabetes mellitus in USA (Unknown route)